PolyPeptide Group AG
41.75 CHF-3.55 (-7.84%)
ListedCHF1.4BHealthcareDrug Manufacturers - Specialty & Generic1,440 employees
Key Executives(10)
Mr. Michael Staheli
Head of Investor Relations & Corporate Communications
Age61
CompensationNot disclosed
Mr. Olivier Ludemann-Hombourger
Director of Global Innovation & Technology
Age54
CompensationNot disclosed
Mr. Tim Brandl
Interim CFO and Director of Investor Relations, Financial Planning & Analysis
CompensationNot disclosed
Ms. Christina Del Vecchio
Chief Legal Officer & Corporate Secretary
Age48
CompensationNot disclosed